Oxford Immunotec Global PLC OXFD Income Statement

Oxford immunotec global plc (OXFD)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Revenue:
Revenue
72,832	73,710	70,963	65,794	62,863	59,753	36,483	35,444	44,907	54,733	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product
-	-	-	-	-	-	-	-	-	-	-	-	-	-	35,306	33,903	31,223	30,207	28,260	26,430	25,704	25,407	24,209	22,706	22,609	19,905	0	0	0
Service
-	-	-	-	-	-	-	-	-	-	-	-	-	-	43,852	37,090	34,868	32,575	29,855	27,066	25,328	24,098	23,403	22,307	20,770	18,879	0	0	0
Total revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	79,158	70,993	66,091	62,782	58,115	53,496	51,032	49,505	47,612	45,013	43,379	38,784	0	0	0
Cost of revenue:
Cost of revenue
18,664	19,288	19,315	18,157	17,295	16,826	3,104	3,778	11,732	18,470	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Product
-	-	-	-	-	-	-	-	-	-	-	-	-	-	14,006	14,147	13,520	13,297	12,130	11,317	11,254	11,225	10,515	9,729	9,459	8,475	0	0	0
Service
-	-	-	-	-	-	-	-	-	-	-	-	-	-	22,586	19,011	17,534	16,247	14,588	13,844	13,398	12,784	12,437	11,642	10,786	10,125	0	0	0
Total cost of revenue
-	-	-	-	-	-	-	-	-	-	-	-	-	-	36,592	33,158	31,054	29,544	26,718	25,161	24,652	24,009	22,952	21,371	20,245	18,600	0	0	0
Gross profit
54,168	54,422	51,648	47,637	45,568	42,927	33,379	31,666	33,175	36,263	30,798	35,640	32,560	30,497	42,566	37,835	35,037	33,238	31,397	28,335	26,380	25,496	24,660	23,642	23,134	20,184	0	0	0
Operating expenses:
Research and development
9,031	8,698	8,197	8,320	8,080	8,122	6,120	7,297	9,396	10,835	10,217	10,818	10,154	9,370	11,826	11,481	11,043	10,381	11,168	9,927	8,596	6,961	4,748	3,381	2,396	2,146	0	0	0
Sales and marketing
29,354	28,424	27,014	26,041	25,628	26,500	22,770	23,595	26,564	29,053	27,131	28,668	28,018	26,858	34,518	33,105	31,441	30,402	29,660	29,747	28,363	25,487	22,089	17,946	14,822	13,270	0	0	0
General and administrative
24,129	22,313	22,833	25,434	25,600	25,952	22,867	21,801	24,134	25,450	24,650	24,050	21,211	18,918	20,422	18,093	16,726	16,010	15,178	14,608	14,792	14,837	15,109	15,626	13,911	12,119	0	0	0
Change in fair value of contingent purchase price consideration
-	-	-	-	-	-	-	-	-	-3,475	-3,415	-2,478	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of contingent purchase price consideration
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Intangible assets impairment charges
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible assets impairment charge
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Settlement expense
-	1,110	1,216	629	2,085	2,193	2,176	2,160	10,235	10,028	0	0	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
63,525	60,545	60,139	61,303	62,272	63,646	61,169	72,273	87,511	90,191	79,803	71,021	57,528	55,703	67,559	63,412	59,886	57,414	56,078	54,354	51,823	47,357	41,946	36,953	31,129	27,535	0	0	0
Operating loss from continuing operations
-9,357	-6,123	-8,491	-13,666	-16,704	-20,719	-27,790	-40,607	-54,336	-53,928	-49,005	-35,381	-24,968	-25,206	-24,993	-25,577	-24,849	-24,176	-24,681	-26,019	-25,443	-21,861	-17,286	-13,311	-7,995	-7,351	0	0	0
Other income (expense):
Interest income
3,666	4,247	3,640	1,903	7	-1,797	-2,705	-2,813	-2,886	-3,105	-3,187	-2,460	-1,670	-864	-102	-67	-69	-67	-1	-23	-32	-52	-176	-274	-324	-328	0	0	0
Foreign exchange gains (losses)
-102	-1,949	184	-228	-670	111	-879	-1,451	-1,847	-1,850	-1,620	-526	895	1,364	1,597	1,603	55	-143	-54	-454	-42	-352	-798	-1,595	-1,521	-423	0	0	0
Other income (expense)
-	-	0	0	-	-271	-189	-194	-121	-209	-665	-771	-620	-646	-239	-197	-219	54	125	280	354	245	-414	-618	-662	-470	0	0	0
Loss from continuing operations before income taxes
-5,725	-3,757	-6,736	-14,078	-19,691	-24,781	-4,063	-17,565	-31,690	-31,592	-54,477	-39,138	-26,363	-25,352	-23,737	-24,238	-25,082	-24,332	-24,611	-26,216	-25,163	-22,020	-18,674	-15,798	-10,502	-8,572	0	0	0
Income tax benefit (expense) from continuing operations
-671	-2,417	-39,698	-39,596	-38,886	-37,286	0	0	0	-	-6,055	-6,217	-3,762	-	144	130	134	146	169	176	169	154	136	98	114	92	0	0	0
Loss from continuing operations
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (loss) from continuing operations
-	-	32,962	25,518	-	12,505	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Discontinued operations:
Income from discontinued operations before income taxes
0	-	0	-	-	1,727	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax expense from discontinued operations
0	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (loss) from discontinued operations
-	-	0	-	-	108,274	0	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-6,340	-1,809	140,871	136,670	129,609	120,779	-11,481	-24,844	-35,139	-32,885	-46,543	-33,692	-23,372	-22,349	-23,881	-24,368	-25,216	-24,478	-24,780	-26,392	-25,332	-22,174	-18,810	-15,896	-10,616	-8,664	0	0	0
Net loss per ordinary share - basic and diluted:
Income (loss) from continuing operations (in dollars per share)
-	-	0.04	0.02	-	-	-0.24	-0.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (loss) from discontinued operations (in dollars per share)
-	-	-0.02	-	-	-	0.11	-0.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) (in dollars per share)
-	-	0.03	0.02	-	-	-0.13	-0.25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) per ordinary share—diluted:
Income (loss) from continuing operations (in dollars per share)
-	-	0.04	0.02	-	-	-0.24	-0.22	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income (loss) from discontinued operations (in dollars per share)
-	-	-0.02	-	-	-	0.11	-0.03	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net income (loss) (in dollars per share)
-	-	0.03	0.02	-	-	-0.13	-0.25	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Basic (in shares)
-	-	26,751	26,625	-	-	26,033	25,845	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in shares)
-	-	26,936	26,889	-	-	26,033	25,845	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from continuing operations (in dollars per share)
-0.20	-	-	-	-0.06	-	-	-	-0.32	-	-0.81	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations (in dollars per share)
-	-	-	-	-	-	-	-	-0.08	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss from discontinued operations (in dollars per share)
-0.03	-	-	-	-	-	-	-	-	-	0.11	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss (in dollars per share)
-0.23	-	-	-	-0.06	-	-	-	-0.40	-	-0.70	-0.74	-0.36	-	-0.18	-0.29	-0.32	-0.28	-0.20	-0.33	-0.31	-0.39	-0.35	-0.36	-0.18	0.08	-1.36	-0.42	-0.56
Weighted-average shares used to compute net loss per ordinary share - basic and diluted (in shares)
26,140	-	-	-	26,515	-	-	-	25,718	-	24,123	22,805	22,533	-	22,365	22,351	22,284	22,290	22,259	22,245	20,331	17,350	17,333	17,292	17,264	8,583	2,331	2,253	2,154
Product [Member]
Revenue
-	-	67,073	62,053	-	54,687	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of goods and services sold
-	-	17,981	16,532	-	13,668	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Service [Member]
Revenue
-	-	3,890	3,741	-	5,066	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of goods and services sold
-	-	1,334	1,625	-	3,158	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-